Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode

Nirmal S Mann, B. B. Borkar, K. P. Narenderan, R. S. Kadian, Surinder K Mann, R. L. Martin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Colonic pH was continuously monitored by a pH electrode implanted in the transverse colon of rats over a 24-hr period. Lactulose significantly reduced the colonic pH to 5.37 ± .39 from a fasting value of 6.77 ± .75. Pretreatment with neomycin or concomitant use of a nonabsorbable antacid prevented lactulose-induced reduction in the colonic pH. The clinical implication of the study is that combined use of lactulose with neomycin or high doses of non-absorbable antacids in the treatment of chronic portasystemic encephalopathy may be undesirable.

Original languageEnglish (US)
Pages (from-to)141-145
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume72
Issue number2
StatePublished - 1979
Externally publishedYes

Fingerprint

Lactulose
Antacids
Implanted Electrodes
Neomycin
Chronic Brain Damage
Transverse Colon
Fasting

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode. / Mann, Nirmal S; Borkar, B. B.; Narenderan, K. P.; Kadian, R. S.; Mann, Surinder K; Martin, R. L.

In: American Journal of Gastroenterology, Vol. 72, No. 2, 1979, p. 141-145.

Research output: Contribution to journalArticle

@article{74fcd36189914b5eb0e75c7cbbf23dee,
title = "Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode",
abstract = "Colonic pH was continuously monitored by a pH electrode implanted in the transverse colon of rats over a 24-hr period. Lactulose significantly reduced the colonic pH to 5.37 ± .39 from a fasting value of 6.77 ± .75. Pretreatment with neomycin or concomitant use of a nonabsorbable antacid prevented lactulose-induced reduction in the colonic pH. The clinical implication of the study is that combined use of lactulose with neomycin or high doses of non-absorbable antacids in the treatment of chronic portasystemic encephalopathy may be undesirable.",
author = "Mann, {Nirmal S} and Borkar, {B. B.} and Narenderan, {K. P.} and Kadian, {R. S.} and Mann, {Surinder K} and Martin, {R. L.}",
year = "1979",
language = "English (US)",
volume = "72",
pages = "141--145",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode

AU - Mann, Nirmal S

AU - Borkar, B. B.

AU - Narenderan, K. P.

AU - Kadian, R. S.

AU - Mann, Surinder K

AU - Martin, R. L.

PY - 1979

Y1 - 1979

N2 - Colonic pH was continuously monitored by a pH electrode implanted in the transverse colon of rats over a 24-hr period. Lactulose significantly reduced the colonic pH to 5.37 ± .39 from a fasting value of 6.77 ± .75. Pretreatment with neomycin or concomitant use of a nonabsorbable antacid prevented lactulose-induced reduction in the colonic pH. The clinical implication of the study is that combined use of lactulose with neomycin or high doses of non-absorbable antacids in the treatment of chronic portasystemic encephalopathy may be undesirable.

AB - Colonic pH was continuously monitored by a pH electrode implanted in the transverse colon of rats over a 24-hr period. Lactulose significantly reduced the colonic pH to 5.37 ± .39 from a fasting value of 6.77 ± .75. Pretreatment with neomycin or concomitant use of a nonabsorbable antacid prevented lactulose-induced reduction in the colonic pH. The clinical implication of the study is that combined use of lactulose with neomycin or high doses of non-absorbable antacids in the treatment of chronic portasystemic encephalopathy may be undesirable.

UR - http://www.scopus.com/inward/record.url?scp=0018366040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018366040&partnerID=8YFLogxK

M3 - Article

C2 - 38663

AN - SCOPUS:0018366040

VL - 72

SP - 141

EP - 145

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 2

ER -